4D Molecular Therapeutics, Inc.
FDMTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How 4D Molecular Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 25, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Evergreen Quality Fund GP, Ltd. | 2026-03-31 | 951,474 | $8.86M | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 9,975 | $92.9K | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 124,228 | $1.16M | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 10,746 | $100K | SEC filing |
| EntryPoint Capital, LLC | 2026-03-31 | 21,602 | $201K | SEC filing |
| CITIGROUP INC | 2026-03-31 | 26,180 | $244K | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 125 | $1.23K | SEC filing |
| GROUP ONE TRADING LLC | 2026-03-31 | 1,998 | $18.6K | SEC filing |
| DEUTSCHE BANK AG\ | 2026-03-31 | 708,044 | $6.59M | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 39,694 | $370K | SEC filing |
| VANGUARD FIDUCIARY TRUST CO | 2026-03-31 | 269,295 | $2.51M | SEC filing |
| COMMONWEALTH EQUITY SERVICES, LLC | 2026-03-31 | 28,274 | $263K | SEC filing |
| ROYAL BANK OF CANADA | 2026-03-31 | 979 | $9K | SEC filing |
| Allworth Financial LP | 2026-03-31 | 509 | $4.74K | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 53 | $493 | SEC filing |
| ArrowMark Colorado Holdings LLC | 2026-03-31 | 202,864 | $1.89M | SEC filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2026-03-31 | 2,195,578 | $20.4M | SEC filing |
| Marshall & Sterling Wealth Advisors Inc. | 2026-03-31 | 100 | $931 | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2026-03-31 | 6 | $56 | SEC filing |
| Woodline Partners LP | 2026-03-31 | 200,001 | $1.86M | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among 4D Molecular Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-22 · Kirn David: Larger than 70 of the 71 other insider sales of Common Stock on file. SEC filing
- 2024-02-08 · Kirn David: Larger than 69 of the 71 other insider sales of Common Stock on file. SEC filing
- 2024-01-05 · Kirn David: Larger than 65 of the 71 other insider sales of Common Stock on file. SEC filing
- 2024-01-04 · VIKING GLOBAL INVESTORS LP: Larger than all 71 other insider sales of Common Stock on file. SEC filing
- 2024-01-04 · Kirn David: Larger than 68 of the 71 other insider sales of Common Stock on file. SEC filing
- 2023-12-15 · Kirn David: Larger than 66 of the 71 other insider sales of Common Stock on file. SEC filing
- 2022-12-16 · Kirn David: Larger than 64 of the 71 other insider sales of Common Stock on file. SEC filing
- 2022-12-15 · Kirn David: Larger than 67 of the 71 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-23 | Bizily Scott · Chief Legal Officer | Common Stock | S — Open market or private sale | −9,810 | 12.00 | SEC filing |
| 2026-06-22 | Kirn David · See Remarks | Common Stock | S — Open market or private sale | −114,746 | 10.47 | SEC filing |
| 2026-06-01 | Kirn David · See Remarks | Common Stock | S — Open market or private sale | −1,922 | 10.02 | SEC filing |
| 2026-03-20 | Gupta Ashoo · VP, Finance and Controller | Common Stock | S — Open market or private sale | −310 | 8.61 | SEC filing |
| 2026-03-20 | Gupta Ashoo · VP, Finance and Controller | Common Stock | S — Open market or private sale | −80 | 8.61 | SEC filing |
| 2025-12-20 | Gupta Ashoo · VP, Finance and Controller | Common Stock | S — Open market or private sale | −310 | 8.68 | SEC filing |
| 2025-12-20 | Gupta Ashoo · VP, Finance and Controller | Common Stock | S — Open market or private sale | −79 | 8.68 | SEC filing |
| 2025-12-16 | Bizily Scott · Chief Legal Officer | Common Stock | S — Open market or private sale | −1,635 | 10.90 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-23 | Bizily Scott · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +9,810 | SEC filing |
| 2026-06-23 | Bizily Scott · Chief Legal Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −9,810 | SEC filing |
| 2026-06-17 | SBLENDORIO GLENN · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-06-17 | Chacko Jacob · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-06-17 | Miller-Rich Nancy · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-06-17 | THEUER CHARLES · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-06-17 | GRAY SUSANNAH · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2026-06-17 | MILLIGAN JOHN F · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +75,000 | SEC filing |
Showing 8 of 22 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-12-09 | RA Capital Healthcare Fund LP · 10% owner | Pre-Funded Warrants (Right to Buy) | J — Other acquisition or disposition | +535,000 | SEC filing |
| 2024-12-09 | RA Capital Healthcare Fund LP · 10% owner | Common Stock | J — Other acquisition or disposition | −535,000 | SEC filing |
| 2024-11-08 | BIOTECHNOLOGY VALUE FUND L P · Other | Pre-Funded Warrant | J — Other acquisition or disposition | +240,000 | SEC filing |
| 2024-11-08 | BIOTECHNOLOGY VALUE FUND L P · Other | Pre-Funded Warrant | J — Other acquisition or disposition | +2,378,000 | SEC filing |
| 2024-11-08 | BIOTECHNOLOGY VALUE FUND L P · Other | Common Stock, $0.0001 par value | J — Other acquisition or disposition | −3,062,000 | SEC filing |
| 2024-11-08 | BIOTECHNOLOGY VALUE FUND L P · Other | Common Stock, $0.0001 par value | J — Other acquisition or disposition | −2,378,000 | SEC filing |
| 2024-11-08 | BIOTECHNOLOGY VALUE FUND L P · Other | Pre-Funded Warrant | J — Other acquisition or disposition | +3,062,000 | SEC filing |
| 2024-11-08 | BIOTECHNOLOGY VALUE FUND L P · Other | Common Stock, $0.0001 par value | J — Other acquisition or disposition | −240,000 | SEC filing |
Showing 8 of 8 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.